<DOC>
	<DOCNO>NCT03017287</DOCNO>
	<brief_summary>The study evaluate safety efficacy computerize GlucoMe App patient uncontrolled diabetes treat MDI .</brief_summary>
	<brief_title>Safety Efficacy GlucoMe APP Patients With Uncontrolled Diabetes Treated With MDI</brief_title>
	<detailed_description>GlucoMe interactive system , provide glucose management tool patient health care team ( HCT ) . The system include decision support system use HCT aim aid clinical decision make mathematical model . The system intend replace clinical judgement recommendation approve HCT . Forty ( 40 ) diabetic patient multiple daily insulin injection ( MDI ) abnormal HbA1c identify potential end user device recruit study screen accord study inclusion exclusion criterion . Patient 's daily blood glucose measure GlucoMe App give recommendation change insulin dose , well recommendation pre post-meal carbohydrate exercise . Patient 's daily blood glucose level follow HCT biweekly 12 week patient instructed change insulin dose accord decision treating physician . At end study , HCT 's recommendation treatment adjustment compare system safety efficacy . Study subject HCT ask complete questionnaire regard GlucoMe system usability .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<criteria>1 . Both type 1 type 2 diabetes 2 . HbA1c 711 % 3 . Treated MDI least 3 month 4 . Ability use system home , mobile phone 1 . Active CAD , CVA last 6 month 2 . Treatment steroid glucose modify drug 3 . Chronic infection/cancer/other severe disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Glucose blood measurement , glucometer , BGM , Diabetes App</keyword>
</DOC>